Carmichael Hill & Associates’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $910 | Hold |
40
| – | – | ﹤0.01% | 626 |
|
|
2024
Q2 | $521 | Hold |
40
| – | – | ﹤0.01% | 645 |
|
|
2024
Q1 | $701 | Hold |
40
| – | – | ﹤0.01% | 641 |
|
|
2023
Q4 | $872 | Hold |
40
| – | – | ﹤0.01% | 638 |
|
|
2023
Q3 | $614 | Hold |
40
| – | – | ﹤0.01% | 642 |
|
|
2023
Q2 | $952 | Hold |
40
| – | – | ﹤0.01% | 634 |
|
|
2023
Q1 | $1.02K | Hold |
40
| – | – | ﹤0.01% | 628 |
|
|
2022
Q4 | $1.17K | Hold |
40
| – | – | ﹤0.01% | 595 |
|
|
2022
Q3 | $1K | Hold |
40
| – | – | ﹤0.01% | 684 |
|
|
2022
Q2 | $0 | Buy |
+40
| New | – | ﹤0.01% | 783 |
|